Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel tyrosine-protein kinase BTK inhibitors presented by Bristol-Myers Squibb

March 16, 2011

Novel series of protein kinase inhibitors presented by Merck & Co.

March 16, 2011

Interim phase I data support safety and promising activity of namitecan in solid tumors

March 15, 2011

Teysuno approved in E.U. for advanced gastric cancer

March 15, 2011

Phase II trial of PD-0332991 advances in patients with KRAS-mutant colorectal cancer

March 15, 2011

New tetrahydroisoquinoline derivatives for cancer patented by University of Tennessee

March 15, 2011

Simcere files IND in China for APX-003

March 15, 2011

Georgetown University investigators design novel apoptosis inducers

March 15, 2011

Array BioPharma and Genentech prepare new B-raf inhibitors

March 15, 2011

Phase I trial of E-3810 under way in patients with advanced cancer

March 15, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...